Graybug Vision Inc

+0.01 (+1.50%)
Products, Mergers / Acquisitions

Graybug And Calcimedica Enter Into Definitive Merger Agreement

Published: 11/22/2022 00:01 GMT
Graybug Vision Inc (GRAY) - Graybug and Calcimedica Enter Into Definitive Merger Agreement.
Graybug- Combined Company Expected to Be Funded With Cash and Equivalents of Approx $35 Million, With an Expected Runway Into Second Half of 2024.
Rachel Leheny, Phd, Will Serve As Chief Executive Officer of the Combined Company.
Phase 2b Results in Acute Pancreatitis for Lead Product Candidate Auxora Expected in Second Half of 2023.
Graybug Vision- Graybug Equity Holders Are Expected to Collectively Own About 29% of Combined Company.